$THMO
ThermoGenesis Holdings, Inc. Stock $thmo

$thmo Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000143774924017521 Filed on May 17, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$2.737M	$2.406M
YoY Change	6.42%	-10.09%
Cost Of Revenue	$1.535M	$2.444M
YoY Change	4.64%	7.1%
Gross Profit	$1.202M	-$38.00K
YoY Change	8.78%	-109.64%
Gross Profit Margin	43.92%	-1.58%
Selling, General & Admin	$1.548M	$1.875M
YoY Change	-16.05%	18.75%
% of Gross Profit	128.79%
Research & Development	$211.0K	$329.0K
YoY Change	-31.05%	-3.8%
% of Gross Profit	17.55%
Depreciation & Amortization	$334.0K	$327.0K
YoY Change	25.09%	25.77%
% of Gross Profit	27.79%
Operating Expenses	$1.759M	$2.204M
YoY Change	-18.19%	14.73%
Operating Profit	-$557.0K	-$2.242M
YoY Change	-46.7%	46.82%
Interest Expense	$1.452M	-$3.343M
YoY Change	-62.8%	63.55%
% of Operating Profit
Other Income/Expense, Net	$8.000K	$22.00K
YoY Change	60.0%	-1200.0%
Pretax Income	-$2.001M	-$7.599M
YoY Change	-61.39%	112.68%
Income Tax
% Of Pretax Income
Net Earnings	-$2.001M	-$7.014M
YoY Change	-61.39%	104.31%
Net Earnings / Revenue	-73.11%	-291.52%
Basic Earnings Per Share	-$0.46
Diluted Earnings Per Share	-$0.46	-$2.18
COMMON SHARES
Basic Shares Outstanding	4.026M	3.137M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.176M	$2.000M
YoY Change	-79.91%	-52.12%
Cash & Equivalents	$1.176M	$2.000M
Short-Term Investments
Other Short-Term Assets	$780.0K	$825.0K
YoY Change	6.27%	-45.29%
Inventory	$1.246M	$1.406M
Prepaid Expenses
Receivables	$1.149M	$949.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.351M	$5.180M
YoY Change	-60.33%	-52.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.474M	$5.796M
YoY Change	28.12%	362.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$256.0K	$256.0K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$5.736M	$6.052M
YoY Change	-34.68%	-28.82%
TOTAL ASSETS
Total Short-Term Assets	$4.351M	$5.180M
Total Long-Term Assets	$5.736M	$6.052M
Total Assets	$10.09M	$11.23M
YoY Change	-48.93%	-42.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$988.0K	$948.0K
YoY Change	5.78%	15.61%
Accrued Expenses	$1.463M	$1.736M
YoY Change	42.59%	-25.3%
Deferred Revenue	$921.0K	$670.0K
YoY Change	26.34%	-14.32%
Short-Term Debt	$4.206M	$0.00
YoY Change
Long-Term Debt Due	$0.00	$7.656M
YoY Change	-100.0%	13.61%
Total Short-Term Liabilities	$8.304M	$11.76M
YoY Change	-20.7%	2.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$28.00K	$3.054M
YoY Change	55.56%	17864.71%
Total Long-Term Liabilities	$28.00K	$3.054M
YoY Change	55.56%	17864.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.304M	$11.76M
Total Long-Term Liabilities	$28.00K	$3.054M
Total Liabilities	$11.17M	$12.90M
YoY Change	-24.19%	-19.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$286.0M	-$284.2M
YoY Change	5.44%	6.75%
Common Stock	$8.000K	$4.000K
YoY Change	300.0%	300.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$975.0K	-$1.667M
YoY Change
Total Liabilities & Shareholders Equity	$10.09M	$11.23M
YoY Change	-48.93%	-42.06%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$2.001M	-$7.014M
YoY Change	-61.39%	104.31%
Depreciation, Depletion And Amortization	$334.0K	$327.0K
YoY Change	25.09%	25.77%
Cash From Operating Activities	-$505.0K	-$2.041M
YoY Change	-17.89%	72.67%
INVESTING ACTIVITIES
Capital Expenditures	$20.00K	$193.0K
YoY Change	-97.41%	109.78%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$20.00K	-$193.0K
YoY Change	-97.41%	109.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$299.0K	218.0K
YoY Change	-109.77%	-85.93%
NET CHANGE
Cash From Operating Activities	-$505.0K	-2.041M
Cash From Investing Activities	-$20.00K	-193.0K
Cash From Financing Activities	-$299.0K	218.0K
Net Change In Cash	-$824.0K	-2.016M
YoY Change	-149.19%	-833.09%
FREE CASH FLOW
Cash From Operating Activities	-$505.0K	-$2.041M
Capital Expenditures	$20.00K	$193.0K
Free Cash Flow	-$525.0K	-$2.234M
YoY Change	-62.12%	75.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7952780
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1176000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2000000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1149000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	949000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1246000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1406000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	780000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	825000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	4351000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5180000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2001000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-5182000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3472000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-239000	usd
CY2023Q1	thmo	Inventory Change In Reserve InventoryChangeInReserve	70000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-271000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-58000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	748000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	45000	usd
CY2023Q1	thmo	Increase Decrease In Contract With Customer Liability Current IncreaseDecreaseInContractWithCustomerLiabilityCurrent	-53000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	53000	usd
CY2023Q1	thmo	Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities	-288000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-615000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	771000	usd
CY2023Q1	thmo	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	2640000	usd
CY2024Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	421000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-299000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3061000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1176000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5852000	usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	333-82900
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	ThermoGenesis Holdings, Inc.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3018487
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	2711 Citrus Road
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Rancho Cordova
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95742
CY2024Q1	dei	City Area Code CityAreaCode	916
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	858-5100
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $.001 par value
CY2024Q1	dei	Trading Symbol TradingSymbol	THMO
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2586000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	122000	usd
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	50000	usd
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000811212
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P20271Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P0Y9M
CY2024Q1	thmo	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2474000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	256000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	256000	usd
CY2024Q1	us-gaap	Assets Assets	10087000	usd
CY2023Q4	us-gaap	Assets Assets	11232000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	988000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	948000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	398000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	376000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	921000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	670000	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	4206000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7278000	usd
CY2024Q1	thmo	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	424000	usd
CY2023Q4	thmo	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	634000	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	378000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1367000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1478000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8304000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11762000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2720000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2900000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	122000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	127000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	28000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	27000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	11174000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	14816000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7952780
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7952780
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3617886
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3617886
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	8000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	286877000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	282383000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-286024000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-284168000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	114000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	114000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	975000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1667000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-2062000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-1917000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1087000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3584000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10087000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11232000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2737000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2572000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1535000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1467000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	1202000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1105000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1548000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1844000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	211000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	306000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	1759000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2150000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-557000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1045000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1452000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	3903000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-239000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000	usd
CY2024Q1	thmo	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-1444000	usd
CY2023Q1	thmo	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-4137000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2001000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-5182000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-145000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-96000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1856000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5086000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-5182000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2001000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-5188000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-145000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-96000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1856000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5092000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.46
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.07
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4025787
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1249576
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3584000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10000	usd
CY2024Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-2001000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1087000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3323000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10000	usd
CY2023Q1	thmo	Adjustments To Additional Paid In Capital Debt Discount AdjustmentsToAdditionalPaidInCapitalDebtDiscount	43000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	215000
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	603000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2640000	usd
CY2023Q1	thmo	Stock Issued During Period Shares Exercise Of Warrants StockIssuedDuringPeriodSharesExerciseOfWarrants	158731
CY2023Q1	thmo	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	421000	usd
CY2023Q1	thmo	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	421000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5012000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2001000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	334000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	267000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1052000	usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	usd
CY2024Q1	thmo	Inventory Change In Reserve InventoryChangeInReserve	27000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	199000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-133000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-46000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-778000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	41000	usd
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	75000	usd
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-1103000	usd
CY2024Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	22000	usd
CY2024Q1	thmo	Increase Decrease In Contract With Customer Liability Current IncreaseDecreaseInContractWithCustomerLiabilityCurrent	351000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-211000	usd
CY2024Q1	thmo	Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities	-185000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-505000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-771000	usd
CY2024Q1	thmo	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	99000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	398000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-824000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1675000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4177000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	102000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	140000	usd
CY2024Q1	thmo	Interest Paid Net Related Party InterestPaidNetRelatedParty	317000	usd
CY2023Q1	thmo	Interest Paid Net Related Party InterestPaidNetRelatedParty	1492000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	983000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1359000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1428000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1133000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4903000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1542000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3361000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	125000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2600000000000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	360000000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18151156
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4206312
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1238869
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.14
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P4Y6M25D
	thmo	Warrants Granted During Period WarrantsGrantedDuringPeriod	0
	thmo	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	-0
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1238869
CY2024Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.14
CY2024Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P4Y3M25D
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2737000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2572000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2737000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2572000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	365000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	362000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	921000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	670000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	122000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	127000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1237000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	557000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	138000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	13000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	80000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2025000	usd
CY2020Q3	thmo	Short Term Investment Minimum ShortTermInvestmentMinimum	1000000	usd

Files In Submission

Name	View Source	Status
0001437749-24-017521-index-headers.html	Edgar Link	pending
0001437749-24-017521-index.html	Edgar Link	pending
0001437749-24-017521.txt	Edgar Link	pending
thmo-20240331_cal.xml	Edgar Link	unprocessable
0001437749-24-017521-xbrl.zip	Edgar Link	pending
ex_669611.htm	Edgar Link	pending
ex_669612.htm	Edgar Link	pending
ex_669613.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thmo-20240331.xsd	Edgar Link	pending
thmo20240331_10q.htm	Edgar Link	pending
thmo-20240331_lab.xml	Edgar Link	unprocessable
thmo-20240331_pre.xml	Edgar Link	unprocessable
thmo20240331_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
thmo-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THMO
ThermoGenesis Holdings, Inc. Stock $thmo

2024 Q1 Form 10-Q Financial Statement

#000143774924017521 Filed on May 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THMO ThermoGenesis Holdings, Inc. Stock $thmo

2024 Q1 Form 10-Q Financial Statement

#000143774924017521 Filed on May 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THMO
ThermoGenesis Holdings, Inc. Stock $thmo